1. United States Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Vector Science and Therapeutics Corp.

Vector Science and Therapeutics Corp.

1.32
USD
-0.08
(-6.06%)
-0.04EPS

Share Statistics

As of May 31, 2026, VECTOR SCI & THERAPEUTICS CORP has 153.49M shares outstanding.

Shares Outstanding153.49M

Financial Position

As of May 31, 2026, VECTOR SCI & THERAPEUTICS CORP maintains a current ratio of 4.73, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities.

Current Ratio4.73
Quick Ratio3.26
Interest Coverage-45.21

Income Statement

USD

These figures cover the twelve months ended May 31, 2026.

Pretax Income-2.59M

Balance Sheet

USD

These figures are as of May 31, 2026. Total book value stands at 2.00M, with working capital of 1.83M providing operational flexibility.

Cash & Cash Equivalents1.09M
Net Debt-1.09M
Equity (Book Value)2.00M
Book Value Per Share0.01
Working Capital1.83M

Cash Flow

USD

These figures cover the twelve months ended May 31, 2026. After subtracting -58,425.00 in capital expenditures, free cash flow totaled -866,623.00 - equivalent to -0.01 per share.

Capital Expenditures-58,425.00
Free Cash Flow-866,623.00
FCF Per Share-0.01